Stuart Sedlack,

Head, Corporate Development

Stuart Sedlack serves as Head, Corporate Development. He has over 25 years of experience in the pharmaceutical industry, leading corporate business development activities and closing numerous transactions. Prior to joining Sebela Pharmaceuticals, Stuart was Senior Vice President, Corporate Development at Velocity Pharmaceutical Development, Amarin Pharma and Alba Therapeutics, serving as a member of the executive team at each company. Stuart also headed transaction negotiations for Novartis Pharma’s infectious disease franchise and served as Vice President, Corporate Development at Elan Corporation after serving as Director at the University of Maryland Medical System’s tech transfer office. Before entering the pharma industry, Stuart spent 5 years in international trade banking.

Stuart holds a BS in Economics from the University of Richmond and an MBA from Babson College.